Article
Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene delivery.
Gene therapy - 1 Apr 2012
Sénac J S, Chandler R J, Sysol J R, Li L, Venditti C P
Abstract excerpt
Methylmalonic acidemia (MMA), an inherited metabolic disorder caused by deficient activity of methylmalonyl-CoA mutase, carries a poor prognosis for long-term survival. While administration of a recombinant adeno-associated virus serotype 8 vector (rAAV8) can rescue Mut(-/-) mice from neonatal lethality and provide sustained phenotypic correction, translation of gene therapy to human subjects will likely require...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
